TICKERNERD
Menu
BKDBKDHealthcare · Medical Care Facilities

BKD Stock Forecast: Brookdale Senior Living, Inc. Price Predictions for 2026-2027

Last close, 3 Sept 2026
$12
+0.17% on the day

The 6 Wall Street analysts covering Brookdale Senior Living, Inc. hold a median 12-month price target of $18 — +52.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 2 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$2.9B
Ticker Nerd rank
78 / 100
Median analyst target
$18
Analysts covering
6
Revenue$764.9M−6.0% y/y
Operating income$53.9M
Net income−$6.9M
Free cash flow−$25.6M
Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.2%
1M
−16.9%
YTD
+10.7%
1Y
+56.5%
From 52W high
−28.8%
From 52W low
+62.2%
$7
$17
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BKD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Brookdale Senior Living, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Sept 2026
78 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
82
Growth
81
Momentum
76
Accruals
71
Revisions
70
Issuance
68
Quality
48
Value
42
Size
31

Volatility (82): The share price has been relatively steady.

Value (42): The shares cost a lot relative to the profits and assets behind them.

Size (31): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BKD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BKD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20Oct 25Jan 26Apr 26Jul 26BKDHigh $23Median $18Low $17

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says6 analysts
6 Buy0 Hold0 Sell
Low $17Median $18High $23

The green dot is the last close — the median target sits +52.8% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
11 Aug 2026BarclaysMaintainsOverweight$18 → $17
15 June 2026Compass PointInitiatesBuy$22
15 June 2026Compass PointInitiatesBuy—
9 Apr 2026Stephens & Co.InitiatesOverweight—
3 Feb 2026BarclaysMaintainsOverweight—
29 Jan 2026RBC CapitalMaintainsOutperform—
22 Jan 2026BarclaysMaintainsOverweight—
6 Jan 2026B of A SecuritiesUpgradeBuy—
17 Nov 2025RBC CapitalMaintainsOutperform—
11 Nov 2025BarclaysUpgradeOverweight—
10 Nov 2025BarclaysMaintainsEqual-Weight—
7 Aug 2025BarclaysMaintainsEqual-Weight—
9 July 2025RBC CapitalReiteratesOutperform—
8 May 2025RBC CapitalMaintainsOutperform—
16 Apr 2025BarclaysMaintainsEqual-Weight—
10 Apr 2025RBC CapitalReiteratesOutperform—
1 Apr 2025BarclaysInitiatesEqual-Weight—
12 Mar 2025MacquarieMaintainsOutperform—
20 Feb 2025RBC CapitalReiteratesOutperform—
20 Dec 2024MacquarieMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BKD appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

BKD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 3 Sept 2026, Brookdale Senior Living, Inc. returned +56.5% against +21.4% for the S&P 500, dividends included.

BKD vs S&P 500, last 12 monthsTotal return, rebased to 100
100120140160180200220Oct 25Jan 26Apr 26Jul 26BKDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BKD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Brookdale Senior Living, Inc. (BKD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−10.7×

Cheaper than 93% of US stocks

Price / sales
1.0×

Cheaper than 70% of US stocks

Price / book
−52.1×

Cheaper than 99% of US stocks

EV / EBITDA
17.1×

Cheaper than 19% of US stocks

Growth & margins
Revenue growth (YoY)
−8.9%

Higher than 16% of US stocks

Earnings growth (YoY)
−6.0%

Higher than 29% of US stocks

Gross margin
28.3%

Higher than 32% of US stocks

Operating margin
6.8%

Higher than 58% of US stocks

Net margin
−4.7%

Higher than 24% of US stocks

Returns & dividend
Return on equity
−349.6%

Higher than 4% of US stocks

Return on assets
1.5%

Higher than 55% of US stocks

Dividend yield
8.4%

Higher than 90% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Brookdale Senior Living, Inc. (BKD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Brookdale Senior Living, Inc. has a market value of $2.9B and an enterprise value of $8.0B.

  • Revenue in the twelve months to 31 Mar 2026: $3.1B. The latest quarter shrank 8.9% year on year.

  • Net income over the same four quarters: −$204.7M, a −6.5% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.86.

  • Free cash flow in the twelve months to 31 Mar 2026: $9.3M, after $206.2M of capital spending.

  • Shares outstanding: 238.8M.

  • Trailing P/E: −10.7×; forward P/E: 70.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 8.37%, paying out 0% of earnings.

  • Brookdale Senior Living, Inc. employs 22,440 people — $140K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 4 Sept 2026

Data provided by Twelve Data

Peers

BKD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
BKDBrookdale Senior Living, Inc.$2.9B
78
AVAHAveanna Healthcare Holdings, Inc.$2.9B
87
ACHCAcadia Healthcare Co., Inc.$2.6B
52
GRDNGuardian Pharmacy Services, Inc.$2.5B
81
NHCNational HealthCare Corp.$3.4B
66
MDPediatrix Medical Group, Inc.$2.2B
99
ADUSAddus HomeCare Corp.$2.2B
96

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Brookdale Senior Living, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BKD news & analysis

Are Medical Stocks Lagging Brookdale Senior Living (BKD) This Year?

Zacks Investment Research · 1 Sept 2026neutral

Zacks Investment Research compares the year-to-date performance of Brookdale Senior Living (BKD) and Biomea Fusion (BMEA) against their sector. The article examines how the two medical stocks have fared relative to their industry so far this year.

Why it matters — This comparison gives Brookdale Senior Living watchers a benchmark for how the stock is performing versus its sector and a peer in the medical space.

Down 17.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Brookdale (BKD)

Zacks Investment Research · 20 Aug 2026positive

Brookdale (BKD) has declined 17.3% over the past four weeks and is now considered technically oversold. Analysts are revising earnings estimates higher, suggesting the stock may be set for a trend reversal.

Why it matters — A BKD watcher would care because the combination of oversold technical conditions and upward earnings estimate revisions points to a potential rebound in the stock after its recent sharp decline.

Brookdale Senior Living: Portfolio Shrinkage Is Hiding A Better Earnings Base

Seeking Alpha · 12 Aug 2026positive

Brookdale Senior Living is selling underperforming assets and focusing on owned communities. Despite declining total revenue, same-community RevPAR rose 5.5%, adjusted EBITDA increased 4.3%, and adjusted free cash flow nearly doubled year-over-year.

Why it matters — A BKD watcher would care because the portfolio optimization and strong same-community metrics suggest the company may be building a stronger earnings base despite top-line shrinkage.

Brookdale Senior Living Inc. (BKD) Q2 2026 Earnings Call Transcript

Seeking Alpha · 11 Aug 2026neutral

Seeking Alpha published the transcript of Brookdale Senior Living Inc.'s Q2 2026 earnings call, covering the company's second-quarter 2026 results and management's discussion.

Why it matters — A BKD watcher would care because the transcript provides the full details of the company's latest quarterly results and management commentary directly from the earnings call.

Brookdale Senior Living Q2 Earnings Call Highlights

MarketBeat · 11 Aug 2026positive

Brookdale Senior Living reaffirmed its 2026 guidance after reporting second-quarter adjusted EBITDA of $122.1 million, up 4.3% from a year earlier. Stronger pricing and cost-management efforts helped offset slower-than-expected occupancy progress.

Why it matters — BKD watchers would care because the company reaffirmed its 2026 outlook while posting year-over-year EBITDA growth despite headwinds from slower occupancy gains.

FAQ

Frequently asked questions about BKD stock

What is the BKD stock price forecast for 2026-2027?

The 6 Wall Street analysts covering Brookdale Senior Living, Inc. have a median 12-month price target of $18, with estimates ranging from $17 to $23. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BKD stock a buy right now?

Of the 6 analysts covering Brookdale Senior Living, Inc., 6 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Brookdale Senior Living, Inc. 78 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BKD?

As at 2 Sept 2026, Brookdale Senior Living, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (82 of 100).

Will BKD stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts implies +52.8% from the last close, and Ticker Nerd's factor model ranks Brookdale Senior Living, Inc. 78 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BKD stock forecast for 2030?

No analyst covering Brookdale Senior Living, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BKD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $17 to $23 over the next 12 months.

How has BKD stock performed over the past year?

Brookdale Senior Living, Inc. returned +56.5% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Brookdale Senior Living, Inc. do?

Brookdale Senior Living Inc. is a U.S.-based senior living operator focused on housing, care, and support services for older adults.

What is the latest news on BKD?

The most recent item we track (Zacks Investment Research, 1 Sept 2026): "Are Medical Stocks Lagging Brookdale Senior Living (BKD) This Year?". Zacks Investment Research compares the year-to-date performance of Brookdale Senior Living (BKD) and Biomea Fusion (BMEA) against their sector. The article examines how the two medical stocks have fared relative to their industry so far this year.

Company

About Brookdale Senior Living, Inc.

Brookdale Senior Living Inc. is a U.S.-based senior living operator focused on housing, care, and support services for older adults. Brookdale Senior Living Inc. provides independent living, assisted living, memory care, and continuing care retirement communities across the United States, serving residents through communities designed for different levels of daily support and specialized care. The company’s services combine residential living with hospitality, wellness, and personal care offerings, making it a key provider in the senior housing and healthcare services market. Brookdale Senior Living Inc. also works within the broader continuum of senior care, helping meet needs that range from active retirement lifestyles to more advanced memory and assistance requirements.

CEO Mr. Nikolas W. Stengle · 22,440 employees · United States · https://www.brookdale.com